OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Feliza Mirasol is the science editor for BioPharm International.
The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.
Large-scale single-use bioreactors prove successful as limits are tested.
SUB bioreactor performance has had seen its limits and successes.
Establishing a data management strategy in-lab is a first step in generating successful analytical studies.